|Day Low/High||92.11 / 95.87|
|52 Wk Low/High||66.93 / 101.73|
Here are Wednesday's top research calls, including downgrades for Chipotle and Arconic, an upgrade for Big Lots and new coverage of Snap.
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company") (Nasdaq: ESRX) concerning possible violations of...
The Nasdaq settles above its 6,000 milestone for the first time ever and scores a new record close by the end of the session.
Express Scripts is losing its largest customer.
Levi & Korsinsky, LLP announces it has commenced an investigation of Express Scripts Holding Company ("Express Scripts") (NASDAQ:ESRX) concerning possible violations of federal securities laws.
Better-than-expected earnings from industry leaders including Caterpillar and McDonald's push the Dow to log triple-digit gains for the second day in a row, its best two-day stretch of the year.
Khang & Khang LLP (the "Firm") announces that it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company") (Nasdaq: ESRX) concerning possible violations of federal securities...
U.S. stock futures are set for solid gains and European stocks soar after the first round of France's elections put centrist Emmanuel Macron in the lead for the presidency.
But also remember that this week earnings will run wild, with nearly 200 members of the S&P 500 reporting.
Here are five things you must know for Monday, April 24.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
Its earnings are more than double what they were five years ago, but the stock price is the same.
Attorney Advertising. On March 17, 2017, the nationally recognized class-action law firm of Keller Rohrback L.
Chuck Grassley is hammering the privately held drug company on its $4,500 EpiPen competitor.
I believe this president goes full Trumpian tonight, in a style that he has made all his own.
The pharmaceutical distributor is finally turning around.
It used the earning's call to pass much of the blame for high drug prices onto pharmaceutical companies.
The country's largest pharmacy benefits manager is enjoying tailwinds after reporting a big jump in year-over-year profits.
The pharmacy benefit manager shifted blame for drug pricing back to pharma companies.
Kaleo's EpiPen compeitor the Auvi-Q was released today.
The Auvi-Q was released Feb. 14, but it's unclear whether patients will break up with their current option, EpiPen, for something new.
BLL, OPK, ESRX, SKYW and DLA all were recently downgraded by TheStreet's Quant Ratings.
Jim Cramer likes European banks, plus Banco Santander, and New York Community Bancorp, too.
Jim Cramer takes a closer look at the risks: Don't measure 'Trump per share,' measure actual earnings per share.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AG, AMZN, CBPX, CTLT, FSM, GOLD, LADR, OHI Downgrades: ESRX, GCO, NXPI, OPB, PIP, RDY, TM Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
The most ethnically and gender diverse boards may surprise you.
The comparison to the New York mob boss was only the beginning of Citron Research's inflammatory comments
Real Money contributor Stephen Guilfoyle sees some reasons for caution in stock trading right now.
It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree to pay to keep Auvi-Q free for most patients.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.